Clinical Trial Update: A Study of Dementia and Neurological Problems in HIV Infected Patients Who Are Participating in ACTG A5175

View source ↗

Summary

This ClinicalTrials.gov entry reports on dementia and neurological problems in HIV-infected patients enrolled in ACTG A5175; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia
• HIV Infection
• Hiv-associated Neurocognitive Disorder

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV Infections | Status: COMPLETED